Recent Blog Posts
A recent appellate court decision provides guidance on the limits of permissible discovery in a qui tam action filed under the False Claims Act (FCA). In United States ex rel. Duxbury v. Ortho Biotech Products, L.P., Case No. 12-2141 (1st Cir., Jun. 12, 2013), the United States Court of Appeals for the First Circuit held… Read More »
In its three years of existence, the Securities and Exchange Commission’s (SEC) whistleblower program has produced only one $50,000 payout. But within the next couple of months, it will produce “incredibly impactful cases” with “some extremely significant whistleblower awards.” That’s the take of Stephen Cohen, Associate Director of the SEC’s Division of Enforcement. “There will… Read More »
More than four dozen hospitals in 21 states have agreed to pay more than $34 million to the U.S. government to settle allegations that they submitted bogus Medicare claims for kyphoplasty, a procedure used to treat certain spinal fractures caused by osteoporosis, the U.S. Department of Justice announced Tuesday. The settlements resolve claims that the… Read More »
Announcing the Launch of Our Blog: Civil Litigation News & Insights Welcome to the blog of the Drakulich Firm. With offices in both California and Nevada, we provide representation in a number of civil litigation cases, such as personal injury, wrongful death, insurance bad faith and business litigation. We have earned the respect of our… Read More »
Fluor Corporation (NYSE: FLR) settled a lawsuit brought by a qui tam relator under the False Claims Act arising from Fluor’s management of the Hazardous Materials Management and Emergency Response (HAMMER) facility. The U.S. Department of Energy (DOE) commissioned HAMMER for the training of emergency first responders. Fluor Hanford, Inc., a Fluor subsidiary, managed the… Read More »
Lloyd’s of London shouldn’t have to help Huron Consulting Group Inc. defend against a $50 million whistleblower suit tied to Medicare and Medicaid overbilling at now-defunct St. Vincent Catholic Medical Centers because its policy doesn’t cover government lawsuits, the insurer’s attorney told a New York state judge Tuesday. More information about this suit can be… Read More »
A federal judge in the Eastern District of Pennsylvania has dismissed a whistleblower suit against AstraZeneca Pharmaceuticals that alleged the drug manufacturer entered into fraudulent agreements to sell its brand-name drugs. More information about this suit can be found here. The Drakulich Firm is a California qui tam law office.